export const pathways = [
  {
    id: 'alpha1',
    name: 'α1-Adrenergic Pathway',
    receptor: 'α1',
    location: 'Vascular smooth muscle, myocardium',
    gProtein: 'Gq',
    secondMessenger: 'IP3/DAG',
    mechanism: [
      'Agonist binds to α1 receptor',
      'Gq protein activates phospholipase C (PLC)',
      'PLC cleaves PIP2 → IP3 + DAG',
      'IP3 releases Ca²⁺ from sarcoplasmic reticulum',
      'Ca²⁺ binds calmodulin',
      'Activates myosin light chain kinase',
      'Smooth muscle contraction',
    ],
    primaryEffects: [
      'Vasoconstriction',
      'Increased SVR',
      'Increased blood pressure',
      'Mydriasis (pupil dilation)',
      'Urinary retention',
    ],
    clinicalSignificance: 'Primary target for vasopressor therapy in shock states',
  },
  {
    id: 'alpha2',
    name: 'α2-Adrenergic Pathway',
    receptor: 'α2',
    location: 'Presynaptic nerve terminals, CNS, vascular smooth muscle',
    gProtein: 'Gi',
    secondMessenger: 'Decreased cAMP',
    mechanism: [
      'Agonist binds to α2 receptor',
      'Gi protein inhibits adenylyl cyclase',
      'Decreased cAMP production',
      'Reduced neurotransmitter release (presynaptic)',
      'Decreased sympathetic outflow (CNS)',
      'K⁺ channel opening, Ca²⁺ channel closing',
    ],
    primaryEffects: [
      'Negative feedback on NE release',
      'Decreased sympathetic tone',
      'Sedation (CNS)',
      'Decreased insulin secretion',
      'Platelet aggregation',
    ],
    clinicalSignificance: 'Target for sedatives (dexmedetomidine) and antihypertensives (clonidine)',
  },
  {
    id: 'beta1',
    name: 'β1-Adrenergic Pathway',
    receptor: 'β1',
    location: 'Cardiac muscle, kidney (JGA)',
    gProtein: 'Gs',
    secondMessenger: 'cAMP',
    mechanism: [
      'Agonist binds to β1 receptor',
      'Gs protein activates adenylyl cyclase',
      'ATP → cAMP',
      'cAMP activates protein kinase A (PKA)',
      'PKA phosphorylates:',
      '  - L-type Ca²⁺ channels (↑ Ca²⁺ influx)',
      '  - Phospholamban (↑ SR Ca²⁺ reuptake)',
      '  - Troponin I (↓ Ca²⁺ sensitivity)',
    ],
    primaryEffects: [
      'Increased heart rate (chronotropy)',
      'Increased contractility (inotropy)',
      'Increased conduction velocity (dromotropy)',
      'Increased automaticity',
      'Renin release',
    ],
    clinicalSignificance: 'Primary target for inotropes in heart failure and β-blockers in CAD',
  },
  {
    id: 'beta2',
    name: 'β2-Adrenergic Pathway',
    receptor: 'β2',
    location: 'Bronchial smooth muscle, vascular smooth muscle, skeletal muscle',
    gProtein: 'Gs',
    secondMessenger: 'cAMP',
    mechanism: [
      'Agonist binds to β2 receptor',
      'Gs protein activates adenylyl cyclase',
      'ATP → cAMP',
      'cAMP activates protein kinase A (PKA)',
      'PKA phosphorylates myosin light chain kinase',
      'Decreased MLCK activity',
      'Smooth muscle relaxation',
    ],
    primaryEffects: [
      'Bronchodilation',
      'Vasodilation (skeletal muscle)',
      'Decreased SVR',
      'Tremor',
      'Glycogenolysis',
      'K⁺ uptake into cells',
    ],
    clinicalSignificance: 'Primary target for bronchodilators in asthma/COPD',
  },
  {
    id: 'beta3',
    name: 'β3-Adrenergic Pathway',
    receptor: 'β3',
    location: 'Adipose tissue, bladder detrusor muscle',
    gProtein: 'Gs',
    secondMessenger: 'cAMP',
    mechanism: [
      'Agonist binds to β3 receptor',
      'Gs protein activates adenylyl cyclase',
      'ATP → cAMP',
      'cAMP activates protein kinase A (PKA)',
      'PKA activates hormone-sensitive lipase',
      'Triglycerides → Free fatty acids + Glycerol',
    ],
    primaryEffects: [
      'Lipolysis',
      'Thermogenesis',
      'Bladder relaxation',
      'Reduced detrusor tone',
    ],
    clinicalSignificance: 'Target for overactive bladder treatment (mirabegron)',
  },
  {
    id: 'downstream',
    name: 'Integrated Cardiovascular Response',
    receptor: 'Multiple',
    location: 'Systemic',
    gProtein: 'Multiple',
    secondMessenger: 'Multiple',
    mechanism: [
      'Adrenergic stimulation affects:',
      '  1. Heart (β1): ↑ HR, ↑ contractility',
      '  2. Vessels (α1): Vasoconstriction',
      '  3. Vessels (β2): Vasodilation',
      '  4. Lungs (β2): Bronchodilation',
      'Net hemodynamic effect depends on:',
      '  - Receptor selectivity',
      '  - Tissue distribution',
      '  - Dose',
      'CO = HR × SV',
      'BP = CO × SVR',
    ],
    primaryEffects: [
      'Blood pressure regulation',
      'Cardiac output optimization',
      'Tissue perfusion',
      'Metabolic effects',
    ],
    clinicalSignificance: 'Understanding integrated response crucial for rational drug selection',
  },
];
